BC
Bicara Therapeutics Inc. Common Stock
BCAX · NASDAQ
$22.64 -0.53% (-$0.12)
1M -3.99%
Market Cap $1.48B
P/E Ratio -
Div. Yield -
ROE 41.49%
Piotroski F-Score Weak
1/9Valuation
64 /100
Fair P/B 3.17x
P/E N/A
EV/EBITDA N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
Book val. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
FCF margin N/A
Quality
0 /100
Poor ROIC 43.01%
ROE 41.49%
Asset turnover 0.00x
Debt
100 /100
Low Debt/Equity 0.00x
Current ratio 11.59x
Int. coverage N/A
Stability
39 /100
Moderate Beta -0.82x
EPS volatility 41.20%
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre BCAX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Claire Mazumdar Clemon
Employees
103
Headquarters
Boston
Evenimente viitoare
09 NOV.
Earnings
Upcoming earnings report